Camber Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-400,000
Closed -$86.3M 38
2024
Q1
$86.3M Buy
+400,000
New +$93.7M 3.02% 16
2022
Q4
Sell
-200,000
Closed -$53.4M 40
2022
Q3
$53.4M Buy
200,000
+75,000
+60% +$15.9M 1.79% 22
2022
Q2
$25.5M Buy
+125,000
New +$25.6M 1.11% 23
2022
Q1
Sell
-250,000
Closed -$60M 39
2021
Q4
$60M Buy
250,000
+175,000
+233% +$45M 2.31% 22
2021
Q3
$21.2M Buy
+75,000
New +$24.6M 0.79% 35
2021
Q1
Sell
-200,000
Closed -$49M 37
2020
Q4
$49M Buy
+200,000
New +$51.6M 2.01% 19
2020
Q2
Sell
-200,000
Closed -$63.3M 32
2020
Q1
$63.3M Sell
200,000
-150,000
-43% -$45.5M 3.78% 12
2019
Q4
$104M Hold
350,000
5.37% 3
2019
Q3
$81.5M Buy
+350,000
New +$81.5M 4.63% 8
2019
Q2
Sell
-400,000
Closed -$94.6M 32
2019
Q1
$94.6M Buy
400,000
+150,000
+60% +$47.2M 5.48% 6
2018
Q4
$75.2M Sell
250,000
-50,000
-17% -$16M 4.07% 11
2018
Q3
$106M Sell
300,000
-150,000
-33% -$51.6M 6.04% 7
2018
Q2
$131M Sell
450,000
-65,000
-13% -$18.3M 6.11% 4
2018
Q1
$141M Buy
+515,000
New +$160M 6.92% 4
2017
Q3
Sell
-100,000
Closed -$27.1M 24
2017
Q2
$27.1M Buy
+100,000
New +$26.4M 1.66% 22
2017
Q1
Sell
-175,000
Closed -$49.6M 34
2016
Q4
$49.6M Buy
+175,000
New +$51.9M 2.87% 19
2016
Q3
Sell
-275,000
Closed -$66.5M 38
2016
Q2
$66.5M Buy
275,000
+100,000
+57% +$26.4M 3.87% 8
2016
Q1
$45.6M Buy
+175,000
New +$46.2M 2.83% 17

Other funds holding BIIB